At a glance
- Originator B Braun Medical
- Class Antibacterials; Cephalosporins; Small molecules
- Mechanism of Action Cell wall inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Bacteraemia; Bone and joint infections; CNS infections; Gynaecological infections; Intra-abdominal infections; Respiratory tract infections; Skin and soft tissue infections